These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 12673696

  • 1. Progress in the chemotherapy of metastatic cancer of the urinary tract.
    Raghavan D.
    Cancer; 2003 Apr 15; 97(8 Suppl):2050-5. PubMed ID: 12673696
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z, Dimopoulos MA, Kostakopoulos A, Karayiannis A, Sofras F, Zervas A, Giannopoulos A, Dimopoulos C.
    J Urol; 1997 Aug 15; 158(2):408-11. PubMed ID: 9224313
    [Abstract] [Full Text] [Related]

  • 3. New developments in first- and second-line chemotherapy for transitional cell, squamous cell and adenocarcinoma of the bladder.
    De Santis M, Bachner M.
    Curr Opin Urol; 2007 Sep 15; 17(5):363-8. PubMed ID: 17762632
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 15; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 5. Overview of bladder cancer trials in the European Organization for Research and Treatment.
    de Wit R, European Organization for Research and Treatment.
    Cancer; 2003 Apr 15; 97(8 Suppl):2120-6. PubMed ID: 12673705
    [Abstract] [Full Text] [Related]

  • 6. Advanced bladder and urothelial cancers.
    Raghavan D.
    Eur J Cancer; 2000 Jul 15; 36 Suppl 2():1-6. PubMed ID: 10908841
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
    Tsavaris N, Kosmas C, Skopelitis H, Dimitrakopoulos A, Kopterides P, Bougas D, Stravodimos K, Mitropoulos D, Alamanis C, Giannopoulos A.
    J Chemother; 2005 Aug 15; 17(4):441-8. PubMed ID: 16167525
    [Abstract] [Full Text] [Related]

  • 8. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
    Galsky MD, Iasonos A, Mironov S, Scattergood J, Donat SM, Bochner BH, Herr HW, Russo P, Boyle MG, Bajorin DF.
    Urology; 2007 Feb 15; 69(2):255-9. PubMed ID: 17320659
    [Abstract] [Full Text] [Related]

  • 9. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.
    Eur J Surg Oncol; 2009 Apr 15; 35(4):352-5. PubMed ID: 18722076
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
    Shimabukuro T, Nakamura K, Uchiyama K, Tei Y, Aoki A, Naito K.
    Hinyokika Kiyo; 2006 Feb 15; 52(2):99-105. PubMed ID: 16541762
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS.
    Urology; 2007 Aug 15; 70(2):257-62. PubMed ID: 17826485
    [Abstract] [Full Text] [Related]

  • 13. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium.
    Dreicer R, Manola J, Roth BJ, See WA, Kuross S, Edelman MJ, Hudes GR, Wilding G.
    Cancer; 2004 Apr 15; 100(8):1639-45. PubMed ID: 15073851
    [Abstract] [Full Text] [Related]

  • 14. Update on chemotherapy for advanced bladder cancer.
    Rosenberg JE, Carroll PR, Small EJ.
    J Urol; 2005 Jul 15; 174(1):14-20. PubMed ID: 15947569
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
    Nieuwenhuijzen JA, Bex A, Meinhardt W, Kerst JM, Schornagel JH, VAN Tinteren H, Horenblas S.
    J Urol; 2005 Jul 15; 174(1):80-5. PubMed ID: 15947583
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy for advanced bladder cancer.
    Roth BJ.
    Semin Oncol; 1996 Oct 15; 23(5):633-44. PubMed ID: 8893874
    [Abstract] [Full Text] [Related]

  • 17. [Chemotherapy of bladder carcinoma. Current status and trends].
    Block T.
    Urologe A; 1994 Nov 15; 33(6):557-67. PubMed ID: 7817457
    [Abstract] [Full Text] [Related]

  • 18. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
    Pectasides D, Pectasides M, Economopoulos T.
    Cancer Treat Rev; 2006 Oct 15; 32(6):456-70. PubMed ID: 16935429
    [Abstract] [Full Text] [Related]

  • 19. Management of disseminated disease in the patient with bladder cancer.
    Perry JJ, Muss HB.
    Urol Clin North Am; 1994 Nov 15; 21(4):661-72. PubMed ID: 7974898
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer.
    Schrier BP, Peters M, Barentsz JO, Witjes JA.
    Eur Urol; 2006 Apr 15; 49(4):698-703. PubMed ID: 16464531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.